Nikki Martin is Senior Director of Precision Medicine Initiatives where she focuses on accelerating access to precision medicine, especially biomarker testing, for lung cancer patients. Nikki came into patient advocacy from multiple roles in public affairs and communications at diagnostic and biotech companies including Genentech, Novartis Diagnostics, and Grifols where she collaborated with patient advocacy groups and other stakeholders on a variety of global health issues. She believes that patient advocacy organizations play an essential role in convening influential entities from government to providers, payers, and industry, which can lead to critical work with long-lasting impact on patient care. Nikki started her career in healthcare communications in Japan where she advised healthcare clients on public relations activities in the Japanese market.